300 related articles for article (PubMed ID: 28639883)
1. Cancer immunotherapy: Breakthrough or "deja vu, all over again"?
Sell S
Tumour Biol; 2017 Jun; 39(6):1010428317707764. PubMed ID: 28639883
[TBL] [Abstract][Full Text] [Related]
2. Talkin' Toxins: From Coley's to Modern Cancer Immunotherapy.
Carlson RD; Flickinger JC; Snook AE
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32283684
[TBL] [Abstract][Full Text] [Related]
3. Advances in strategies and methodologies in cancer immunotherapy.
Lam SS; Zhou F; Hode T; Nordquist RE; Alleruzzo L; Raker J; Chen WR
Discov Med; 2015 Apr; 19(105):293-301. PubMed ID: 25977192
[TBL] [Abstract][Full Text] [Related]
4. Towards the era of immune checkpoint inhibitors and personalized cancer immunotherapy.
Nakajima H; Nakatsura T
Immunol Med; 2021 Mar; 44(1):10-15. PubMed ID: 32643578
[TBL] [Abstract][Full Text] [Related]
5. Considerations for the combination of anticancer vaccines and immune checkpoint inhibitors.
Strauss J; Madan RA; Gulley JL
Expert Opin Biol Ther; 2016 Jul; 16(7):895-901. PubMed ID: 27010190
[TBL] [Abstract][Full Text] [Related]
6. Current perspectives on immunotherapy.
Weber JS
Semin Oncol; 2014 Oct; 41 Suppl 5():S14-29. PubMed ID: 25438996
[TBL] [Abstract][Full Text] [Related]
7. Vaccines versus immunotherapy: overview of approaches in deciding between options.
Dalgleish AG
Hum Vaccin Immunother; 2014; 10(11):3369-74. PubMed ID: 25625932
[TBL] [Abstract][Full Text] [Related]
8. [Recent progress of cancer immunology and immunotherapy].
Kawakami Y
Nihon Rinsho; 2017 Feb; 75(2):175-180. PubMed ID: 30562849
[TBL] [Abstract][Full Text] [Related]
9. Advances in Therapeutic Cancer Vaccines.
Wong KK; Li WA; Mooney DJ; Dranoff G
Adv Immunol; 2016; 130():191-249. PubMed ID: 26923002
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer: role of the immune system in cancer progression and vaccine-based immunotherapy.
Amedei A; Niccolai E; Prisco D
Hum Vaccin Immunother; 2014; 10(11):3354-68. PubMed ID: 25483688
[TBL] [Abstract][Full Text] [Related]
11. DNA vaccine for cancer immunotherapy.
Yang B; Jeang J; Yang A; Wu TC; Hung CF
Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
[TBL] [Abstract][Full Text] [Related]
12. Phase I clinical trial of mixed bacterial vaccine (Coley's toxins) in patients with NY-ESO-1 expressing cancers: immunological effects and clinical activity.
Karbach J; Neumann A; Brand K; Wahle C; Siegel E; Maeurer M; Ritter E; Tsuji T; Gnjatic S; Old LJ; Ritter G; Jäger E
Clin Cancer Res; 2012 Oct; 18(19):5449-59. PubMed ID: 22847809
[TBL] [Abstract][Full Text] [Related]
13. A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting.
Gray A; Raff AB; Chiriva-Internati M; Chen SY; Kast WM
Immunol Rev; 2008 Apr; 222():316-27. PubMed ID: 18364011
[TBL] [Abstract][Full Text] [Related]
14. Cancer vaccines: what do we need to measure in clinical trials?
Kudrin A
Hum Vaccin Immunother; 2014; 10(11):3236-40. PubMed ID: 25483508
[TBL] [Abstract][Full Text] [Related]
15. Future approaches in immunotherapy.
Rini B
Semin Oncol; 2014 Oct; 41 Suppl 5():S30-40. PubMed ID: 25438998
[TBL] [Abstract][Full Text] [Related]
16. Cancer Neoantigens and Applications for Immunotherapy.
Desrichard A; Snyder A; Chan TA
Clin Cancer Res; 2016 Feb; 22(4):807-12. PubMed ID: 26515495
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?
Zöller M
Technol Cancer Res Treat; 2003 Jun; 2(3):237-60. PubMed ID: 12779354
[TBL] [Abstract][Full Text] [Related]
18. On immunotherapies and cancer vaccination protocols: a mathematical modelling approach.
Joshi B; Wang X; Banerjee S; Tian H; Matzavinos A; Chaplain MA
J Theor Biol; 2009 Aug; 259(4):820-7. PubMed ID: 19446568
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of immunotherapy.
Disis ML
Semin Oncol; 2014 Oct; 41 Suppl 5():S3-13. PubMed ID: 25438997
[TBL] [Abstract][Full Text] [Related]
20. [New directions in immunotherapy for malignant solid tumors].
Okuno K; Sugiura F; Sukegawa Y; Inoue K
Nihon Rinsho; 2012 Dec; 70(12):2075-86. PubMed ID: 23259377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
